Medical device manufacturing and distribution company METAPHARM reported an operating profit of 2.2 billion won in the first quarter, continuing a streak of profitability for 16 consecutive quarters.
METAPHARM noted on the 2nd that its operating profit in the first quarter was 2.2 billion won, a 57% increase compared to the same period last year. This marks 16 consecutive quarters of profitability.
Sales in the first quarter reached 12.5 billion won, a 69% increase compared to the same period last year, setting a new record for quarterly performance since its inception.
A representative of METAPHARM said, "Since acquiring the dental implant specialist company EZEN Implant, related businesses have intensified, resulting in significant growth in performance."
Specializing in absorbable sutures known as "mini-ting," METAPHARM acquired EZEN Implant in March with the aim of targeting the implant market.
METAPHARM plans to participate in the 32nd International Medical Device Exhibition, "Vietnam Medipharm 2025," to be held in Hanoi, Vietnam, in May to promote its products.
Additionally, METAPHARM has decided to introduce mini-ting in the aesthetic and plastic surgery markets in North America, Europe, and Southeast Asia. The company has set sales targets of 60 billion won and operating profits of 12 billion won for the year.